Because deletion of pink1 in myeloma cells or in the microenvironment promotes myeloma development (Figures 8 and 9), we wanted to test the utility of plasma cell‐free PINK1 DNA as a potential biomarker for mitophagy and for treatment response. This evidence concerns the gene PINK1 and plasma cell myeloma.